GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.376
EU - Europa 15.808
AS - Asia 11.457
SA - Sud America 1.659
AF - Africa 223
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 17
Totale 56.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.025
IT - Italia 5.946
GB - Regno Unito 4.590
CN - Cina 3.805
SG - Singapore 3.641
HK - Hong Kong 1.586
BR - Brasile 1.347
SE - Svezia 1.230
DE - Germania 891
VN - Vietnam 610
FI - Finlandia 574
UA - Ucraina 570
RU - Federazione Russa 567
TR - Turchia 506
FR - Francia 469
KR - Corea 326
ID - Indonesia 257
IN - India 227
BG - Bulgaria 225
NL - Olanda 195
CA - Canada 166
AR - Argentina 133
MX - Messico 124
JP - Giappone 112
ZA - Sudafrica 103
IE - Irlanda 87
ES - Italia 72
PL - Polonia 69
BD - Bangladesh 59
AT - Austria 58
EC - Ecuador 48
LT - Lituania 48
BE - Belgio 46
IR - Iran 38
MY - Malesia 38
IQ - Iraq 36
AE - Emirati Arabi Uniti 35
EG - Egitto 34
AU - Australia 29
RO - Romania 29
VE - Venezuela 27
BZ - Belize 26
MA - Marocco 25
PK - Pakistan 25
CZ - Repubblica Ceca 23
CH - Svizzera 22
PE - Perù 22
PY - Paraguay 22
CO - Colombia 21
SA - Arabia Saudita 20
CL - Cile 19
TN - Tunisia 17
KE - Kenya 14
EU - Europa 13
AL - Albania 12
IL - Israele 12
TH - Thailandia 12
OM - Oman 11
PH - Filippine 11
UZ - Uzbekistan 11
AZ - Azerbaigian 10
JO - Giordania 10
LV - Lettonia 10
PT - Portogallo 10
TW - Taiwan 10
BY - Bielorussia 9
HU - Ungheria 9
UY - Uruguay 9
NP - Nepal 8
BO - Bolivia 7
LU - Lussemburgo 7
GR - Grecia 6
KG - Kirghizistan 6
KZ - Kazakistan 6
AM - Armenia 5
JM - Giamaica 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
DO - Repubblica Dominicana 4
EE - Estonia 4
ET - Etiopia 4
MK - Macedonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SN - Senegal 4
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
MD - Moldavia 3
MV - Maldive 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
GY - Guiana 2
HR - Croazia 2
Totale 56.519
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Santa Clara 3.003
Fairfield 2.598
Singapore 2.314
Ashburn 2.070
Hong Kong 1.582
Woodbridge 1.481
Hefei 1.420
Chandler 1.325
Houston 1.207
Jacksonville 948
Seattle 938
Wilmington 913
Chicago 901
Cambridge 829
Ann Arbor 740
Los Angeles 723
Nyköping 679
London 676
Dearborn 621
Beijing 500
Milan 418
Salt Lake City 412
Modena 378
Rome 371
Helsinki 363
New York 333
Izmir 297
Seoul 295
San Diego 284
The Dalles 240
Princeton 234
Ho Chi Minh City 221
Sofia 221
Jakarta 210
Council Bluffs 195
Tampa 194
Bologna 193
Elk Grove Village 169
Buffalo 168
Dallas 158
Moscow 158
Eugene 157
Shanghai 143
São Paulo 137
Hanoi 128
San Jose 123
Bremen 120
Frankfurt am Main 113
Atlanta 111
Florence 110
Redwood City 104
Naples 102
Munich 93
Des Moines 91
Columbus 89
Palermo 88
Guangzhou 83
Sterling 80
Lancaster 76
Phoenix 76
Tokyo 75
Dublin 72
Parma 67
Kent 65
Catania 64
Bari 62
Detroit 61
Miami 61
Falls Church 59
Mexico City 59
Turin 56
Denver 55
Redondo Beach 54
Warsaw 53
Johannesburg 52
Genoa 51
Norwalk 50
Dulles 49
Montreal 48
Orem 48
Padova 47
Reggio Emilia 47
Verona 47
Boardman 46
Ovada 45
Stockholm 45
Toronto 42
Brooklyn 39
Brussels 39
Chennai 39
New Delhi 39
Nuremberg 39
Belo Horizonte 38
Manchester 37
Delhi 36
Kansas City 36
Lappeenranta 36
Turku 36
Poplar 35
Totale 38.294
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.731
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 872
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 740
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 736
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 408
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 397
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 393
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 391
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 377
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 359
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 356
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 351
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 350
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 345
Thymus alterations and systemic sclerosis 342
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 342
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 340
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 335
Heart involvement and systemic sclerosis 332
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 330
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 329
Scleroderma digital ulcers complicated by infection with fecal pathogens. 322
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 322
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 322
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 320
Current treatment of hepatitis C-associated rheumatic diseases. 310
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 306
Aortic pulse wave velocity measurement in systemic sclerosis patients. 304
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 301
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 300
L-Arginine in pregnant scleroderma patients 300
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 297
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 295
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 294
Elevated Troponin Serum Levels in Adult Onset Still's Disease 287
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 286
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 286
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 285
Platelet gel in the treatment of severe scleroderma skin ulcers. 284
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 284
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 283
HCV and cryoglobulinemic vasculitis. 282
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 281
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 280
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 279
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 278
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 275
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 274
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 273
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 272
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 266
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 264
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 264
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 260
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 260
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 259
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 259
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 255
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 254
Cardiovascular risk and prostanoids in systemic sclerosis 252
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 251
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 251
Amlodipine in the treatment of Raynaud's phenomenon 248
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 248
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 248
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 247
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 247
Associations between Systemic Sclerosis and Thyroid Diseases 246
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 242
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 241
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 237
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 237
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 237
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 235
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 233
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 233
HCV-related rheumatic manifestations and therapeutic strategies 232
Systemic sclerosis following human cytomegalovirus infection 230
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 227
Renal Manifestations of Hepatitis C Virus 225
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 225
HHV-6A infection and systemic sclerosis: Clues of a possible association 224
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 223
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 222
Treatment of HCV-related mixed cryoglobulinemia 221
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 219
The safety of iloprost in systemic sclerosis in a real-life experience 219
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 217
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 217
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 216
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 215
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 215
Novel Therapies for Thyroid Autoimmune Diseases 213
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 212
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 211
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 210
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy] 209
Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis 208
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment 208
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 203
Totale 32.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 231.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.612
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.482 0 0 0 0 0 0 1.048 796 315 526 494 303
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202512.041 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.454
2025/202614.171 1.493 902 1.916 3.447 4.673 1.689 51 0 0 0 0 0
Totale 57.133